Effects of β-blockers therapy on the 28-day and 3-year survival rates of end-stage renal disease patients with cardiovascular disease: a retrospective cohort study

BACKGROUND: β-blockers have been used in the treatment of end-stage renal disease (ESRD) patients and cardiovascular disease (CVD) patients, separately. However, the effects of β-blockers on ESRD patients with CVD have not been fully investigated. This study sought to investigate the effects of β-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong, Wu, Zheqian, Lu, Shijie, Yin, Lili, Chen, Yuandong, Qiu, Canyi, Ng, Pauline Yeung, Durak, Koray, Deana, Cristian, Ding, Fei, Zhang, Zhiyan, Dai, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761132/
https://www.ncbi.nlm.nih.gov/pubmed/36544684
http://dx.doi.org/10.21037/atm-22-5317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761132/
https://www.ncbi.nlm.nih.gov/pubmed/36544684
http://dx.doi.org/10.21037/atm-22-5317

Ejemplares similares